Literature DB >> 34985547

[Minimum volume requirements-perspective of a tertiary care hospital].

Natascha C Nüssler1, Thomas Klier2, Reinhard Ruppert2.   

Abstract

BACKGROUND: The increase of minimum volumes for complex esophageal resections decided by the Federal Joint Committee (GBA) in Germany is currently the subject of intensive discussions.
OBJECTIVE: To shed light on the effects of minimum volume requirements from the perspective of a tertiary care hospital.
RESULTS: Strict adherence to the valid minimum volume requirements for esophageal surgery would significantly reduce the number of hospitals offering these procedures in Germany. The associated loss of revenue should not have any relevant negative economic consequences for most hospitals; however, the loss of complex esophageal surgery may result in a competitive disadvantage for these hospitals in times of shortage of qualified medical personnel. Another point of criticism is the assumption that the treatment quality can be recognized based solely on the numbers of patients.
CONCLUSION: Despite the well-known volume-outcome relationship, minimum volume requirements do not define the lower limit of quality of surgical treatment. Therefore, additional evidence of treatment quality, such as structural or process quality as well as outcome parameters should be required, e.g. through certification. An obligatory synchronous certification could contribute to increasing the acceptance of minimum volume requirements in Germany.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Certification; Esophageal resection; Quality; Surgical training; Treatment quality

Mesh:

Year:  2022        PMID: 34985547     DOI: 10.1007/s00104-021-01557-9

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  1 in total

1.  Hospital Volume, In-Hospital Mortality, and Failure to Rescue in Esophageal Surgery.

Authors:  Ulrike Nimptsch; Thomas Haist; Christian Krautz; Robert Grützmann; Thomas Mansky; Dietmar Lorenz
Journal:  Dtsch Arztebl Int       Date:  2018-11-23       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.